Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-08 · accession 0001209191-22-060580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-09 | 2022-12-08 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $15.79 | -2,543 | 297.0K | -0.8% | -$40.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-08 | S | D | 2,543 | $15.79 | 297,020 | D | — | — | (F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. |